Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04806789Completed

Plasma Sodium: a Predictor of Perforation in Acute Appendicitis. (The NAP-study)

Role: collaborator

NCT05982847Recruiting

National Blood Pressure Screening in Children to Improve Paediatric Healthcare in South Africa

Role: collaborator

NCT03411928Not ApplicableUnknown

Endotracheal Dilator to Improve Oxygenation

Role: collaborator

NCT03052348Not ApplicableUnknown

Efficacy of Combining Topical Antibiotic/Steroid/Moisturizer Therapy Compared to Active Comparator in Atopic Dermatitis.

Role: lead

NCT03185637Completed

Children's Surgery in Sub-Saharan Africa

Role: collaborator

NCT02084472Not ApplicableCompleted

Accessible and Affordable Moisturizers for Atopic Eczema

Role: lead

All 6 trials loaded